- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 239/84 - Atomes d'azote
Détention brevets de la classe C07D 239/84
Brevets de cette classe: 290
Historique des publications depuis 10 ans
|
28
|
20
|
17
|
25
|
27
|
24
|
25
|
20
|
7
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Aic246 AG & Co. KG | 29 |
16 |
| Neupharma, Inc. | 72 |
14 |
| Cornell University | 3396 |
10 |
| ArQule, Inc. | 133 |
9 |
| Blueprint Medicines Corporation | 247 |
8 |
| Gilead Sciences, Inc. | 2190 |
8 |
| HMI Medical Innovations, LLC | 14 |
8 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2976 |
7 |
| Merck Patent GmbH | 5669 |
6 |
| Araxes Pharma LLC | 91 |
6 |
| Institute of Organic Chemistry and Biochemistry of the AS CR, v.v.i. | 13 |
6 |
| Abbisko Therapeutics Co., Ltd. | 117 |
6 |
| Eisai R&D Management Co., Ltd. | 1178 |
5 |
| Merck Sharp & Dohme LLC | 3732 |
5 |
| Bristol-myers Squibb Company | 4815 |
4 |
| Merck Sharp & Dohme Corp. | 2184 |
4 |
| Pfizer Inc. | 3370 |
4 |
| Convergene LLC | 10 |
4 |
| Deciphera Pharmaceuticals, LLC | 245 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 858 |
4 |
| Autres propriétaires | 152 |